Serology for the diagnosis of human hepatic cystic echinococcosis and its relation with cyst staging: A systematic review of the literature with meta-analysis.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
13
07
2020
accepted:
07
04
2021
entrez:
28
4
2021
pubmed:
29
4
2021
medline:
28
7
2021
Statut:
epublish
Résumé
The diagnosis of cystic echinococcosis (CE) is primarily based on imaging, while serology should be applied when imaging is inconclusive. CE cyst stage has been reported among the most important factors influencing the outcome of serodiagnosis. We performed a systematic review and meta-analysis of the relation between cyst stage of hepatic CE and diagnostic sensitivity of serological tests, to evaluate whether their relation is a consistent finding and provide guidance for the interpretation of results of serological tests. MEDLINE, EMBASE, CENTRAL, and Lilacs databases were searched on December 1st 2019. Original studies published after 2003 (year of publication of the CE cyst classification), reporting sensitivity of serological tests applied to the diagnosis of human hepatic CE, as diagnosed and staged by imaging, were included. The quality of studies was assessed using the Newcastle-Ottawa Scale. Data from 14 studies were included in the meta-analysis. Summary estimates of sensitivities and 95% confidence intervals were obtained using random effects meta-analysis. Overall, test sensitivity was highest in the presence of CE2 and CE3 (CE3a and/or CE3b), and lowest in the presence of CE5 and CE4 cysts. ELISA, ICT and WB showed the highest sensitivities, while IHA performed worst. The results of our study confirm the presence of a clear and consistent relation between cyst stage and serological tests results. Limitations of evidence included the heterogeneity of the antigenic preparations used, which prevented to determine whether the relation between cyst stage and sensitivity was influenced by the type of antigenic preparation, the paucity of studies testing the same panel of sera with different assays, and the lack of studies assessing the performance of the same assay in both field and hospital-based settings. Our results indicate the absolute need to consider cyst staging when evaluating serological results of patients with hepatic CE.
Sections du résumé
BACKGROUND
The diagnosis of cystic echinococcosis (CE) is primarily based on imaging, while serology should be applied when imaging is inconclusive. CE cyst stage has been reported among the most important factors influencing the outcome of serodiagnosis. We performed a systematic review and meta-analysis of the relation between cyst stage of hepatic CE and diagnostic sensitivity of serological tests, to evaluate whether their relation is a consistent finding and provide guidance for the interpretation of results of serological tests.
METHODOLOGY/PRINCIPAL FINDINGS
MEDLINE, EMBASE, CENTRAL, and Lilacs databases were searched on December 1st 2019. Original studies published after 2003 (year of publication of the CE cyst classification), reporting sensitivity of serological tests applied to the diagnosis of human hepatic CE, as diagnosed and staged by imaging, were included. The quality of studies was assessed using the Newcastle-Ottawa Scale. Data from 14 studies were included in the meta-analysis. Summary estimates of sensitivities and 95% confidence intervals were obtained using random effects meta-analysis. Overall, test sensitivity was highest in the presence of CE2 and CE3 (CE3a and/or CE3b), and lowest in the presence of CE5 and CE4 cysts. ELISA, ICT and WB showed the highest sensitivities, while IHA performed worst.
CONCLUSIONS/SIGNIFICANCE
The results of our study confirm the presence of a clear and consistent relation between cyst stage and serological tests results. Limitations of evidence included the heterogeneity of the antigenic preparations used, which prevented to determine whether the relation between cyst stage and sensitivity was influenced by the type of antigenic preparation, the paucity of studies testing the same panel of sera with different assays, and the lack of studies assessing the performance of the same assay in both field and hospital-based settings. Our results indicate the absolute need to consider cyst staging when evaluating serological results of patients with hepatic CE.
Identifiants
pubmed: 33909640
doi: 10.1371/journal.pntd.0009370
pii: PNTD-D-20-01261
pmc: PMC8081258
doi:
Substances chimiques
Antibodies, Helminth
0
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009370Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Adv Parasitol. 2017;95:315-493
pubmed: 28131365
Trop Med Int Health. 2007 May;12(5):637-46
pubmed: 17445131
Infection. 2012 Apr;40(2):139-52
pubmed: 22076692
PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004444
pubmed: 26871432
PLoS Negl Trop Dis. 2018 Sep 6;12(9):e0006741
pubmed: 30188936
Parasit Vectors. 2019 Jun 26;12(1):323
pubmed: 31242932
Adv Parasitol. 2017;96:259-369
pubmed: 28212790
PLoS Negl Trop Dis. 2012;6(10):e1880
pubmed: 23145199
PLoS Negl Trop Dis. 2011 Oct;5(10):e1364
pubmed: 22039558
J Natl Cancer Inst. 1959 Apr;22(4):719-48
pubmed: 13655060
Adv Parasitol. 2017;96:159-257
pubmed: 28212789
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Trends Parasitol. 2009 Apr;25(4):164-70
pubmed: 19269248
Am J Trop Med Hyg. 2016 Jan;94(1):166-71
pubmed: 26503271
Trends Parasitol. 2006 Sep;22(9):431-8
pubmed: 16843726
PLoS Negl Trop Dis. 2012;6(7):e1714
pubmed: 22802975
Emerg Infect Dis. 2008 Feb;14(2):260-6
pubmed: 18258119
Curr Opin Infect Dis. 2018 Oct;31(5):383-392
pubmed: 30124496
Clin Infect Dis. 2018 Apr 17;66(9):1342-1351
pubmed: 29149256
Adv Parasitol. 2017;95:213-314
pubmed: 28131364
Am J Trop Med Hyg. 2019 Dec;101(6):1345-1349
pubmed: 31674293
Acta Trop. 2010 Apr;114(1):1-16
pubmed: 19931502
Diagn Microbiol Infect Dis. 2018 Sep;92(1):31-33
pubmed: 29776711
Parasite Immunol. 2013 Dec;35(12):433-40
pubmed: 23834586
Adv Parasitol. 2017;95:65-109
pubmed: 28131366
PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3057
pubmed: 25122222
Emerg Infect Dis. 2006 Feb;12(2):296-303
pubmed: 16494758
Emerg Infect Dis. 2005 Dec;11(12):1866-73
pubmed: 16485472
J Infect Dis. 2003 Dec 15;188(12):1951-60
pubmed: 14673776